SecBot SecBot

BMGL

Basel Medical Group Ltd
Nasdaq· Services-Offices & Clinics of Doctors of Medicine· Inc. D8· CIK 0002004489 Healthcare & Medical Devices
$4.55 +0.11 (+2.48%)
Oct 26 4:00 PM ET · prev $4.44
Market cap
$33.7M
Nano cap
1 year
−75.7%
from $18.72 · Oct 27
30 days
+31.1%
from $3.47
52-week range
$3.02–19.08
−76% from high · low Oct 1
Avg volume 20D
753.3K
shares / day
Short interest
🔒 Subscribers only
Filing reports
10
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 4 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 4/6
Strongest BEARISH Basel Medical Group Ltd closed a registered direct offering of 6,000,000 units at $1.33/unit, raising $7.98M…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendRANGE

    3% above its 50-day average.

Who's buying

13F
Top holderSharesValue
UBS Group AG495$3.4K

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
Basel Medical Group Ltd closed a registered direct offering of 6,000,000 units at $1.33/unit, raising $7.98M gross…
6-K — Impact 7/10
Oct 9, 2026 SEC
Basel Medical Group Ltd is raising up to $6.0 million through a registered direct offering of units, each consisting…
6-K — Impact 5/10
Oct 8, 2026 SEC
Basel Medical Group Ltd has priced a best-efforts public offering of up to 6,000,000 Units at US$1.33 per Unit, each…
424B4 — Impact 7/10
Sep 17, 2026 Trading halt
Halt Resumed: BMGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-17T14:16:59.000Z | Resumed 2026-09-17T14:21:59.000Z
Mar 24, 2026 Press
Basel Medical Group Ltd announced it has resolved its Nasdaq filing deficiency after submitting its amended 2025…
Impact 3/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Sep 17, 2026Volatility PauseResumed
Sep 16, 2026Volatility PauseResumed
Sep 15, 2026Volatility PauseResumed
Sep 14, 2026Volatility PauseResumed
Sep 14, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 17, 2026
Trading halt
Halt Resumed: BMGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-17T14:16:59.000Z | Resumed 2026-09-17T14:21:59.000Z
Sep 17, 2026
Trading halt
Trading Halt: BMGL — LUDP (Volatility Trading Pause)
Basel Medical Group Ltd Ord Sh | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 16, 2026
Trading halt
Halt Resumed: BMGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-16T15:14:55.000Z | Resumed 2026-09-16T15:19:55.000Z
Sep 16, 2026
Trading halt
Trading Halt: BMGL — LUDP (Volatility Trading Pause)
Basel Medical Group Ltd Ord Sh | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 15, 2026
Trading halt
Halt Resumed: BMGL — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-15T19:59:19.000Z | Resumed 2026-09-15T20:00:00.000Z

SecBot reports

10 filings · 1 press release · 0 bullish · 4 bearish · 6 neutral
All BMGL filing & press-release reports (11)